Raymond James Financial Inc. Takes Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)
Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 306,290 shares of the company’s stock, valued at approximately $2,974,000. Several other large investors have also added to or reduced their stakes in the company. […]
Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 306,290 shares of the company’s stock, valued at approximately $2,974,000. Several other large investors have also added to or reduced their stakes in the company. […]
